Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00908583 · ClinicalTrials.gov registry record · Phase 4
Desensitization in Kidney Transplantation
A Phase 4 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
NCT00908583: Completed Phase 4 study, sponsored by University of Cincinnati.
NCT00908583 is a Phase 4 study that has completed, run by University of Cincinnati. The registered enrollment target is 44 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00908583, a Phase 4 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
Study Summary
To determine if deletional strategies will provide effective desensitization.
Primary Outcome
Number of living donor transplant candidates who convert to a negative flow T- and B-cell crossmatch via desensitization and are subsequently transplanted
Interventions
- DRUG Rituximab
- DRUG Methylprednisolone
- DRUG Bortezomib
- DRUG plasmapheresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-11 |
| Phase | Phase 4 |
What the finished NCT00908583 record still lists
NCT00908583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 4 interventions - of which Rituximab is the first listed.
NCT00908583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00908583 about?
NCT00908583 is a clinical study titled "Desensitization in Kidney Transplantation". To determine if deletional strategies will provide effective desensitization.
What is the current status of trial NCT00908583?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2009-05. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00908583?
The interventions under investigation include: Rituximab (DRUG), Methylprednisolone (DRUG), Bortezomib (DRUG), plasmapheresis (DRUG).
Who is sponsoring clinical trial NCT00908583?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00908583's enrollment target sits among peer trials
44 1363rd of 2000 higher than 630 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia